07:03:17 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-29 Ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 Ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2023-02-10 07:00:00
OSLO, NORWAY - 10 FEBRUARY 2023 - Circa Group AS (stock symbol: CIRCA) has
agreed with the French environmental permitting authority to progress with a
full permanent permitting application, which will extend the runway to ReSolute
commissioning by approximately six months.

The French authority, Direction Régionale de l'Environnement, de l'Aménagement
et du Logement (DREAL), Division Moselle, and Circa, have agreed to proceed with
a permanent environmental permit. The permanent permit replaces the temporary
permit that was originally planned for the ReSolute plant located in the Grand
Est region in the north east of France.

This update will see a delay to the current start-up timetable of approximately
six months. During discussions with DREAL it was apparent that the permanent
environmental permit was an overall more efficient and appropriate process for
Circa's technology.

Circa continues to engage with DREAL and all authorities to ensure the
permitting process is as time efficient as possible. Additionally, Circa is
working with all major vendors to maximise equipment pre-fabrication prior to
arrival on site, and reduce final construction timeframes.

Circa Group AS CEO Tony Duncan said "We are working constructively with the
authorities and our vendors towards the commissioning of ReSolute, and plans for
our industrial scale FC6 future plant remain on track. Our FC5 plant continues
to support organisations trialling the potential of CyreneTM in their industrial
processes and continues to supply Merck, OQEMA, Will & Co, and direct customers
in Europe, Australia, Japan, US and elsewhere with volumes needed for early
market development."



About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food, biomass and addressing a gap in the market by
providing bio-based alternatives contributing to a more circular economy.
https://circa-group.com



Media Contact
Amanda Keogh
General Manager Marketing and Sustainability
Circa Group
Amanda.keogh@circa-group.com
Tel: +61 407 275 126


Investor Contact
Tone Leivestad
Chief Financial Officer
Circa Group
tone.leivestad@circa-group.com
Tel: +47 406 39 455